autologous limbal epithelial cell
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02592330)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous limbal epithelial cell
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04773431 | Phase 1 | Jan 31, 2020 | Catholic University of Korea, CliPS Co., Ltd |
| NCT02592330 | Phase 1 | Aug 1, 2016 | Harvard University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2020 |
| CliPS Co., Ltd | For profit | 1 | 1 | 1 | 2020 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1